世界の医薬品医療機器コンビネーション製品市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Drug Device Combination Products Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1982
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、医薬品医療機器コンビネーション製品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬剤溶出性ステント、プレフィルドシリンジ、ウェアラブルインジェクター、インスリンインジェクター薬、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・医薬品医療機器コンビネーション製品の市場動向
・企業の競争状況、市場シェア
・医薬品医療機器コンビネーション製品の種類別市場規模（薬剤溶出性ステント、プレフィルドシリンジ、ウェアラブルインジェクター、インスリンインジェクター薬、その他）
・医薬品医療機器コンビネーション製品の用途別市場規模（病院、クリニック、外来手術センター、その他）
・医薬品医療機器コンビネーション製品の北米市場規模2016-2027（アメリカ、カナダ）
・医薬品医療機器コンビネーション製品のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・医薬品医療機器コンビネーション製品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・医薬品医療機器コンビネーション製品の中南米市場規模2016-2027（メキシコ、ブラジル）
・医薬品医療機器コンビネーション製品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott Laboratories、Terumo、Stryker、Mylan、Medtronic、Allergan,、Boston Scientific、Novartis、Teleflex、BD、W.L.Core & Associates、Gerresheimer、Schott、Nipro）
・結論

Market Analysis and Insights: Global Drug Device Combination Products Market
The global Drug Device Combination Products market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Device Combination Products market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Device Combination Products market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Device Combination Products market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Device Combination Products market.

Global Drug Device Combination Products Scope and Market Size
Drug Device Combination Products market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Device Combination Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drug-Eluting Stents
Prefilled Syringes
Wearable Injectors
Insulin Injector Drug
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Terumo
Stryker
Mylan
Medtronic
Allergan,
Boston Scientific
Novartis
Teleflex
Mylan
Medtronic
Gerresheimer

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Device Combination Products Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug-Eluting Stents
1.2.3 Prefilled Syringes
1.2.4 Wearable Injectors
1.2.5 Insulin Injector Drug
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug Device Combination Products Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Drug Device Combination Products Market Perspective (2016-2027)
2.2 Drug Device Combination Products Growth Trends by Regions
2.2.1 Drug Device Combination Products Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Drug Device Combination Products Historic Market Share by Regions (2016-2021)
2.2.3 Drug Device Combination Products Forecasted Market Size by Regions (2022-2027)
2.3 Drug Device Combination Products Industry Dynamic
2.3.1 Drug Device Combination Products Market Trends
2.3.2 Drug Device Combination Products Market Drivers
2.3.3 Drug Device Combination Products Market Challenges
2.3.4 Drug Device Combination Products Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Drug Device Combination Products Players by Revenue
3.1.1 Global Top Drug Device Combination Products Players by Revenue (2016-2021)
3.1.2 Global Drug Device Combination Products Revenue Market Share by Players (2016-2021)
3.2 Global Drug Device Combination Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drug Device Combination Products Revenue
3.4 Global Drug Device Combination Products Market Concentration Ratio
3.4.1 Global Drug Device Combination Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Device Combination Products Revenue in 2020
3.5 Drug Device Combination Products Key Players Head office and Area Served
3.6 Key Players Drug Device Combination Products Product Solution and Service
3.7 Date of Enter into Drug Device Combination Products Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Device Combination Products Breakdown Data by Type
4.1 Global Drug Device Combination Products Historic Market Size by Type (2016-2021)
4.2 Global Drug Device Combination Products Forecasted Market Size by Type (2022-2027)

5 Drug Device Combination Products Breakdown Data by Application
5.1 Global Drug Device Combination Products Historic Market Size by Application (2016-2021)
5.2 Global Drug Device Combination Products Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Drug Device Combination Products Market Size (2016-2027)
6.2 North America Drug Device Combination Products Market Size by Type
6.2.1 North America Drug Device Combination Products Market Size by Type (2016-2021)
6.2.2 North America Drug Device Combination Products Market Size by Type (2022-2027)
6.2.3 North America Drug Device Combination Products Market Size by Type (2016-2027)
6.3 North America Drug Device Combination Products Market Size by Application
6.3.1 North America Drug Device Combination Products Market Size by Application (2016-2021)
6.3.2 North America Drug Device Combination Products Market Size by Application (2022-2027)
6.3.3 North America Drug Device Combination Products Market Size by Application (2016-2027)
6.4 North America Drug Device Combination Products Market Size by Country
6.4.1 North America Drug Device Combination Products Market Size by Country (2016-2021)
6.4.2 North America Drug Device Combination Products Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Drug Device Combination Products Market Size (2016-2027)
7.2 Europe Drug Device Combination Products Market Size by Type
7.2.1 Europe Drug Device Combination Products Market Size by Type (2016-2021)
7.2.2 Europe Drug Device Combination Products Market Size by Type (2022-2027)
7.2.3 Europe Drug Device Combination Products Market Size by Type (2016-2027)
7.3 Europe Drug Device Combination Products Market Size by Application
7.3.1 Europe Drug Device Combination Products Market Size by Application (2016-2021)
7.3.2 Europe Drug Device Combination Products Market Size by Application (2022-2027)
7.3.3 Europe Drug Device Combination Products Market Size by Application (2016-2027)
7.4 Europe Drug Device Combination Products Market Size by Country
7.4.1 Europe Drug Device Combination Products Market Size by Country (2016-2021)
7.4.2 Europe Drug Device Combination Products Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Drug Device Combination Products Market Size (2016-2027)
8.2 Asia-Pacific Drug Device Combination Products Market Size by Type
8.2.1 Asia-Pacific Drug Device Combination Products Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Drug Device Combination Products Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Drug Device Combination Products Market Size by Type (2016-2027)
8.3 Asia-Pacific Drug Device Combination Products Market Size by Application
8.3.1 Asia-Pacific Drug Device Combination Products Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Drug Device Combination Products Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Drug Device Combination Products Market Size by Application (2016-2027)
8.4 Asia-Pacific Drug Device Combination Products Market Size by Region
8.4.1 Asia-Pacific Drug Device Combination Products Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Drug Device Combination Products Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Drug Device Combination Products Market Size (2016-2027)
9.2 Latin America Drug Device Combination Products Market Size by Type
9.2.1 Latin America Drug Device Combination Products Market Size by Type (2016-2021)
9.2.2 Latin America Drug Device Combination Products Market Size by Type (2022-2027)
9.2.3 Latin America Drug Device Combination Products Market Size by Type (2016-2027)
9.3 Latin America Drug Device Combination Products Market Size by Application
9.3.1 Latin America Drug Device Combination Products Market Size by Application (2016-2021)
9.3.2 Latin America Drug Device Combination Products Market Size by Application (2022-2027)
9.3.3 Latin America Drug Device Combination Products Market Size by Application (2016-2027)
9.4 Latin America Drug Device Combination Products Market Size by Country
9.4.1 Latin America Drug Device Combination Products Market Size by Country (2016-2021)
9.4.2 Latin America Drug Device Combination Products Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Drug Device Combination Products Market Size (2016-2027)
10.2 Middle East & Africa Drug Device Combination Products Market Size by Type
10.2.1 Middle East & Africa Drug Device Combination Products Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Drug Device Combination Products Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Drug Device Combination Products Market Size by Type (2016-2027)
10.3 Middle East & Africa Drug Device Combination Products Market Size by Application
10.3.1 Middle East & Africa Drug Device Combination Products Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Drug Device Combination Products Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Drug Device Combination Products Market Size by Application (2016-2027)
10.4 Middle East & Africa Drug Device Combination Products Market Size by Country
10.4.1 Middle East & Africa Drug Device Combination Products Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Drug Device Combination Products Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Drug Device Combination Products Introduction
11.1.4 Abbott Laboratories Revenue in Drug Device Combination Products Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Terumo
11.2.1 Terumo Company Details
11.2.2 Terumo Business Overview
11.2.3 Terumo Drug Device Combination Products Introduction
11.2.4 Terumo Revenue in Drug Device Combination Products Business (2016-2021)
11.2.5 Terumo Recent Development
11.3 Stryker
11.3.1 Stryker Company Details
11.3.2 Stryker Business Overview
11.3.3 Stryker Drug Device Combination Products Introduction
11.3.4 Stryker Revenue in Drug Device Combination Products Business (2016-2021)
11.3.5 Stryker Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Drug Device Combination Products Introduction
11.4.4 Mylan Revenue in Drug Device Combination Products Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Drug Device Combination Products Introduction
11.5.4 Medtronic Revenue in Drug Device Combination Products Business (2016-2021)
11.5.5 Medtronic Recent Development
11.6 Allergan,
11.6.1 Allergan, Company Details
11.6.2 Allergan, Business Overview
11.6.3 Allergan, Drug Device Combination Products Introduction
11.6.4 Allergan, Revenue in Drug Device Combination Products Business (2016-2021)
11.6.5 Allergan, Recent Development
11.7 Boston Scientific
11.7.1 Boston Scientific Company Details
11.7.2 Boston Scientific Business Overview
11.7.3 Boston Scientific Drug Device Combination Products Introduction
11.7.4 Boston Scientific Revenue in Drug Device Combination Products Business (2016-2021)
11.7.5 Boston Scientific Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Drug Device Combination Products Introduction
11.8.4 Novartis Revenue in Drug Device Combination Products Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Teleflex
11.9.1 Teleflex Company Details
11.9.2 Teleflex Business Overview
11.9.3 Teleflex Drug Device Combination Products Introduction
11.9.4 Teleflex Revenue in Drug Device Combination Products Business (2016-2021)
11.9.5 Teleflex Recent Development
11.10 BD
11.10.1 BD Company Details
11.10.2 BD Business Overview
11.10.3 BD Drug Device Combination Products Introduction
11.10.4 BD Revenue in Drug Device Combination Products Business (2016-2021)
11.10.5 BD Recent Development
11.11 W.L.Core & Associates
11.11.1 W.L.Core & Associates Company Details
11.11.2 W.L.Core & Associates Business Overview
11.11.3 W.L.Core & Associates Drug Device Combination Products Introduction
11.11.4 W.L.Core & Associates Revenue in Drug Device Combination Products Business (2016-2021)
11.11.5 W.L.Core & Associates Recent Development
11.12 Gerresheimer
11.12.1 Gerresheimer Company Details
11.12.2 Gerresheimer Business Overview
11.12.3 Gerresheimer Drug Device Combination Products Introduction
11.12.4 Gerresheimer Revenue in Drug Device Combination Products Business (2016-2021)
11.12.5 Gerresheimer Recent Development
11.13 Schott
11.13.1 Schott Company Details
11.13.2 Schott Business Overview
11.13.3 Schott Drug Device Combination Products Introduction
11.13.4 Schott Revenue in Drug Device Combination Products Business (2016-2021)
11.13.5 Schott Recent Development
11.14 Nipro
11.14.1 Nipro Company Details
11.14.2 Nipro Business Overview
11.14.3 Nipro Drug Device Combination Products Introduction
11.14.4 Nipro Revenue in Drug Device Combination Products Business (2016-2021)
11.14.5 Nipro Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Drug Device Combination Products Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug-Eluting Stents
Table 3. Key Players of Prefilled Syringes
Table 4. Key Players of Wearable Injectors
Table 5. Key Players of Insulin Injector Drug
Table 6. Key Players of Others
Table 7. Global Drug Device Combination Products Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Drug Device Combination Products Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Drug Device Combination Products Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Drug Device Combination Products Market Share by Regions (2016-2021)
Table 11. Global Drug Device Combination Products Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Drug Device Combination Products Market Share by Regions (2022-2027)
Table 13. Drug Device Combination Products Market Trends
Table 14. Drug Device Combination Products Market Drivers
Table 15. Drug Device Combination Products Market Challenges
Table 16. Drug Device Combination Products Market Restraints
Table 17. Global Drug Device Combination Products Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Drug Device Combination Products Market Share by Players (2016-2021)
Table 19. Global Top Drug Device Combination Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Device Combination Products as of 2020)
Table 20. Ranking of Global Top Drug Device Combination Products Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Drug Device Combination Products Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drug Device Combination Products Product Solution and Service
Table 24. Date of Enter into Drug Device Combination Products Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug Device Combination Products Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Drug Device Combination Products Revenue Market Share by Type (2016-2021)
Table 28. Global Drug Device Combination Products Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Drug Device Combination Products Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Drug Device Combination Products Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Drug Device Combination Products Revenue Market Share by Application (2016-2021)
Table 32. Global Drug Device Combination Products Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Drug Device Combination Products Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Drug Device Combination Products Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Drug Device Combination Products Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Drug Device Combination Products Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Drug Device Combination Products Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Drug Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Drug Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Drug Device Combination Products Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Drug Device Combination Products Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Drug Device Combination Products Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Drug Device Combination Products Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Drug Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Drug Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Drug Device Combination Products Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Drug Device Combination Products Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Drug Device Combination Products Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Drug Device Combination Products Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Drug Device Combination Products Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Drug Device Combination Products Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Drug Device Combination Products Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Drug Device Combination Products Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Drug Device Combination Products Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Drug Device Combination Products Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Drug Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Drug Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Drug Device Combination Products Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Drug Device Combination Products Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Drug Device Combination Products Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Drug Device Combination Products Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Drug Device Combination Products Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Drug Device Combination Products Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Drug Device Combination Products Product
Table 67. Abbott Laboratories Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Terumo Company Details
Table 70. Terumo Business Overview
Table 71. Terumo Drug Device Combination Products Product
Table 72. Terumo Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 73. Terumo Recent Development
Table 74. Stryker Company Details
Table 75. Stryker Business Overview
Table 76. Stryker Drug Device Combination Products Product
Table 77. Stryker Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 78. Stryker Recent Development
Table 79. Mylan Company Details
Table 80. Mylan Business Overview
Table 81. Mylan Drug Device Combination Products Product
Table 82. Mylan Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 83. Mylan Recent Development
Table 84. Medtronic Company Details
Table 85. Medtronic Business Overview
Table 86. Medtronic Drug Device Combination Products Product
Table 87. Medtronic Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 88. Medtronic Recent Development
Table 89. Allergan, Company Details
Table 90. Allergan, Business Overview
Table 91. Allergan, Drug Device Combination Products Product
Table 92. Allergan, Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 93. Allergan, Recent Development
Table 94. Boston Scientific Company Details
Table 95. Boston Scientific Business Overview
Table 96. Boston Scientific Drug Device Combination Products Product
Table 97. Boston Scientific Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 98. Boston Scientific Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 102. Novartis Recent Development
Table 103. Teleflex Company Details
Table 104. Teleflex Business Overview
Table 105. Teleflex Drug Device Combination Products Product
Table 106. Teleflex Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 107. Teleflex Recent Development
Table 108. BD Company Details
Table 109. BD Business Overview
Table 110. BD Drug Device Combination Products Product
Table 111. BD Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 112. BD Recent Development
Table 113. W.L.Core & Associates Company Details
Table 114. W.L.Core & Associates Business Overview
Table 115. W.L.Core & Associates Drug Device Combination Products Product
Table 116. W.L.Core & Associates Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 117. W.L.Core & Associates Recent Development
Table 118. Gerresheimer Company Details
Table 119. Gerresheimer Business Overview
Table 120. Gerresheimer Drug Device Combination Products Product
Table 121. Gerresheimer Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 122. Gerresheimer Recent Development
Table 123. Schott Company Details
Table 124. Schott Business Overview
Table 125. Schott Drug Device Combination Products Product
Table 126. Schott Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 127. Schott Recent Development
Table 128. Nipro Company Details
Table 129. Nipro Business Overview
Table 130. Nipro Drug Device Combination Products Product
Table 131. Nipro Revenue in Drug Device Combination Products Business (2016-2021) & (US$ Million)
Table 132. Nipro Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Device Combination Products Market Share by Type: 2020 VS 2027
Figure 2. Drug-Eluting Stents Features
Figure 3. Prefilled Syringes Features
Figure 4. Wearable Injectors Features
Figure 5. Insulin Injector Drug Features
Figure 6. Others Features
Figure 7. Global Drug Device Combination Products Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Others Case Studies
Figure 12. Drug Device Combination Products Report Years Considered
Figure 13. Global Drug Device Combination Products Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Drug Device Combination Products Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Drug Device Combination Products Market Share by Regions: 2020 VS 2027
Figure 16. Global Drug Device Combination Products Market Share by Regions (2022-2027)
Figure 17. Global Drug Device Combination Products Market Share by Players in 2020
Figure 18. Global Top Drug Device Combination Products Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Device Combination Products as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Drug Device Combination Products Revenue in 2020
Figure 20. Global Drug Device Combination Products Revenue Market Share by Type (2016-2021)
Figure 21. Global Drug Device Combination Products Revenue Market Share by Type (2022-2027)
Figure 22. North America Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Drug Device Combination Products Market Share by Type (2016-2027)
Figure 24. North America Drug Device Combination Products Market Share by Application (2016-2027)
Figure 25. North America Drug Device Combination Products Market Share by Country (2016-2027)
Figure 26. United States Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Drug Device Combination Products Market Share by Type (2016-2027)
Figure 30. Europe Drug Device Combination Products Market Share by Application (2016-2027)
Figure 31. Europe Drug Device Combination Products Market Share by Country (2016-2027)
Figure 32. Germany Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Drug Device Combination Products Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Drug Device Combination Products Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Drug Device Combination Products Market Share by Region (2016-2027)
Figure 42. China Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Drug Device Combination Products Market Share by Type (2016-2027)
Figure 50. Latin America Drug Device Combination Products Market Share by Application (2016-2027)
Figure 51. Latin America Drug Device Combination Products Market Share by Country (2016-2027)
Figure 52. Mexico Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Drug Device Combination Products Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Drug Device Combination Products Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Drug Device Combination Products Market Share by Country (2016-2027)
Figure 58. Turkey Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Drug Device Combination Products Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Laboratories Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 62. Terumo Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 63. Stryker Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 64. Mylan Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 65. Medtronic Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 66. Allergan, Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 67. Boston Scientific Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 69. Teleflex Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 70. BD Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 71. W.L.Core & Associates Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 72. Gerresheimer Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 73. Schott Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 74. Nipro Revenue Growth Rate in Drug Device Combination Products Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Global Drug Device Combination Products Market Size, Status and Forecast 2021-2027
QYR2104Z1982 2021年4月 96Pages
QYResearch社発行の本調査資料では、医薬品医療機器コンビネーション製品のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬剤溶出性ステント、プレフィルドシリンジ、ウェアラブルインジェクター、インスリンインジェクター薬、その他）、用途別市場...

世界の標的化ドラッグデリバリーデバイス市場規模・現状・予測（2021年-2027年）

Global Targeted Drug Delivery Device Market Size, Status and Forecast 2021-2027
QYR2104Z5554 2021年4月 150Pages
QYResearch社発行の本調査資料では、標的化ドラッグデリバリーデバイスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（目、脳、心臓、胸、腹部、その他）、用途別市場規模（代謝性疾患、眼科疾患、腫瘍性疾患、神経障害、心血管疾患、その他）、主要...

世界のエステティック併用療法市場規模・現状・予測（2021年-2027年）

Global Aesthetics Combination Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z0150 2021年4月 99Pages
QYResearch社発行の本調査資料では、エステティック併用療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（BTx-A /皮膚充填剤、BTx-A /レーザー、レーザー/局所薬、レーザー/高周波、皮膚充填剤/局所薬、その他）、用途別市場規模...

世界のエステティック併用療法市場規模・現状・予測（2021年-2027年）

世界の併用抗体療法市場規模・現状・予測（2021年-2027年）

Global Combination Antibody Therapy Market Size, Status and Forecast 2021-2027
QYR2104Z1458 2021年4月 90Pages
QYResearch社発行の本調査資料では、併用抗体療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法/抗体、抗体/抗体、結合抗体、二重特異性抗体）、用途別市場規模（病院、がん研究所、クリニック、ASC）、主要地域別市場規模（北米、ア...

世界の医療機器洗浄市場規模・現状・予測（2021年-2027年）

Global Medical Device Cleaning Market Size, Status and Forecast 2021-2027
QYR2104Z3616 2021年4月 90Pages
QYResearch社発行の本調査資料では、医療機器洗浄のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（手動式洗浄、自動式洗浄）、用途別市場規模（手術器具、内視鏡、超音波プローブ、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の美学における併用療法市場規模・現状・予測（2021年-2027年）

Global Combination Treatment in Aesthetic Market Size, Status and Forecast 2021-2027
QYR2104Z1460 2021年4月 93Pages
QYResearch社発行の本調査資料では、美学における併用療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ニューロモジュレーター/ラジオ周波数、ニューロモジュレーター/インテンスパルスライト、ニューロモジュレーター/皮膚充填剤、レーザー/...

世界のAAC装置市場規模・現状・予測（2021年-2027年）

Global AAC Device Market Size, Status and Forecast 2021-2027
QYR2104Z0001 2021年4月 94Pages
QYResearch社発行の本調査資料では、AAC装置のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非支援システム、支援システム）、用途別市場規模（脳性麻痺、知的障害、自閉症、パーキンソン病、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界のウェアラブル医療機器用接着剤市場規模・現状・予測（2021年-2027年）

Global Adhesives for Wearable Medical Device Market Size, Status and Forecast 2021-2027
QYR2104Z0103 2021年4月 92Pages
QYResearch社発行の本調査資料では、ウェアラブル医療機器用接着剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アクリル系、シリコーン系、その他）、用途別市場規模（診断装置、監視装置、ドラッグデリバリー装置）、主要地域別市場規模（北米、...

世界のブルートゥースビーコンデバイス市場規模・現状・予測（2021年-2027年）

Global Bluetooth Beacon Device Market Size, Status and Forecast 2021-2027
QYR2104Z0919 2021年4月 97Pages
QYResearch社発行の本調査資料では、ブルートゥースビーコンデバイスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アイビーコン、エディストン、アルトビーコン）、用途別市場規模（小売、旅行・観光、医療、金融機関、その他）、主要地域別市場規...

世界の医薬品医療機器コンビネーション製品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Device Combination Products Market The global Drug Device Combination Products market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
世界の薬剤溶出性生体吸収性ステント市場 2021：企業別、地域別、種類・用途別 The Drug-Eluting Bioabsorbable Stents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
世界の薬剤溶出性ステント（DES）市場 2021：企業別、地域別、種類・用途別 The Drug Eluting Stents (DES) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
世界の標的化ドラッグデリバリーデバイス市場規模・現状・予測（2021年-2027年） Targeted Drug Delivery Device is a method of delivery medication in some parts of the body. This means of delivery is largely founded on nanomedicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would b…
世界のドラッグリポジショニング市場規模・現状・予測（2021年-2027年） Drug repurposing or re-profiling has been the hallmark to bring strong business growth and the trend is being followed by majority of the pharmaceutical and biopharmaceutical companies. Among all biologics approved in the U.S. during 2007-2009, 30-40% of them were the drugs repurposed or repositione…